What types of projects will the Prize award?

The Prize awards applicants from across medical research, biotechnology, computational biology and AI with bold ideas on how to harness the power of AI to identify and validate high-potential therapeutic targets for the discovery of transformative ALS therapeutics.

Eligible applicants who applied for Stage 1 of the Prize had to demonstrate their ability to leverage advanced computational techniques to identify high-potential therapeutic target candidates (or provide new evidence for known but unvalidated targets for ALS) and show a strong commitment to pursuing their validation. 

At Stage 1, successful applications excelled at fulfilling the judging criteria outlined in the Prize Handbook.